Reproducibility study of cervical cytopathology in Mexico: A need for regulation and professional accreditation

Diagnostic Cytopathology

Volumn 17, Issue 1, 1997, Pages 20-24

  Lazcano Ponce, Eduarde César ^a   De Ruiz, Patricia Alonso ^b   Martinez Arias, Carolina ^b   Murguia Riechers, Lourdes ^b  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Concordance; Cytology; Reproducibility

Indexed keywords

ACCREDITATION; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; HUMAN TISSUE; MEXICO; PAPANICOLAOU TEST; PRIORITY JOURNAL; REPRODUCIBILITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CYTOLOGY;

ACCREDITATION; BIOPSY; CYTODIAGNOSIS; FEMALE; HUMANS; MEXICO; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0031011036     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199707)17:1<20::AID-DC4>3.0.CO;2-T     Document Type: Article

References (20)

1. Van der Graaf Y, Zielhuis GA, Vooijs GP. Cervical screening revisited. Acta Cytol 1990;34:366-372.
2. Williams C, Rosenthal D. Cytopathology in the 21st century. Am J Clin Pathol 1993;99(Suppl 1):S31-S33.
3. CLIA 88. Centers for disease control. Regulations for implementing clinical laboratory improvement amendments of 1988: a summary. JAMA 1992;267:1725-1734.
4. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical vaginal cytological diagnoses. JAMA 1989;262:931-934.
5. Koss L, Lin E, Schreiber K, Elgert P, Mango L. Evaluation of the PAPNET cytologic screening system for quality control of cervical smears. Am J Clin Pathol 1994;101:220-229.
6. Anonymous. Data on automated cytology systems as submitted by their developers. Anal Quant Cytol Histol 1991;13:300-306.
7. Wilbur D, Cibas E, Merritt S, James L, Berger B, Bonfiglio T. ThinPrep Processor. Clinical trials demonstrate an increased detection rate of abnormal cervical cytologic specimens. Am J Clin Pathol 1994;101:209-214.
8. Restrepo H, González J, Roberts E, Litvak J. Epidemiología y control del cáncer del cuello uterino en América Latina y el Caribe. Bol Sanit Panam 1987;102:723-726.
9. Alonso P, Lazcano E. Quality control in cytopathology laboratories in six Latin American countries. In: Wied G, Keebler C, Rosenthal D, Schenck U, Somrak T, Vooijs P, eds. Compendium on quality assurance, proficiency testing and workload limitations in clinical cytology. Tutorials of cytology, Chicago, IL, 1995:115-121.
10. Muñoz N, Crawford L, Coursaget P. HPV vacciones for cervical neoplasia. Lancet 1995;345:249.
11. Feinstein AR. A bibliography of publications on observer variability. J Chron Dis 1985;38:619-632.
12. Raab SS. Diagnostic accuracy in cytopathology. Diagn Cytopathol 1994;10:68-75.
13. Kramer MS, Feinstein AR. Clinical biostatistics. LIV. The biostatistics of concordance. Clin Pharmacol Ther 1981;29:111-123.
14. Landis RJ, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
15. SPSS/PC. Statistical package for diseases social sciences, version 4.0.
16. Vooijs P, Van Aspert A, Van't Hof Grootenboer B, Klinkhamer P. Intra-and interobserver variability. In: Wied G, Keebler C, Rosenthal D, Schenck U, Somrak T, Vooijs P, eds. Compendium on quality assurance, proficiency testing and workload limitations in clinical cytology. Tutorials of cytology, Chicago, IL, 1995:15-27.
17. Lundberg G. Quality assurance in cervical cytology. The Papanicolaou smear. JAMA 1989;262:1672-1679.
18. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical-vaginal cytological diagnosis. JAMA 1989;262:931.
19. Okagaki T, Zelterman T. Information, discrimination and divergence in cytology. I. Theoretical aspects and definitions. Anal Quant Cytol Histol 1990;12:342-347.
20. Philip T. Government mandated cytology proficiency testing: time for reality testing. Diagn Cytopathol 1994;10:105-106.